Evidence map›Paper›PMID 42445526›Full record

ArticleCommunications in statistics: Simulation and computation2025

Commensurate prior models with random effects for interval-censored data to accommodate historical controls.

Xi Fang, Brent Logan, Anjishnu Banerjee, Eric Leifer, Pallavi Mishra-Kalyani, Gary L Rosner, Jianjin Xu, Manoj Khanal, Kwang Woo Ahn

Abstract read
In one paragraph

Article in Communications in statistics: Simulation and computation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xi FangYale School of Public Health, Department of Biostatistics, Connecticut, U.S.A.
Brent LoganMedical College of Wisconsin, Division of Biostatistics, Wisconsin, U.S.A.
Anjishnu BanerjeeMedical College of Wisconsin, Division of Biostatistics, Wisconsin, U.S.A.
Eric LeiferNational Heart, Lung, and Blood Institute, Office of Biostatistics Research, Maryland, U.S.A.
Pallavi Mishra-KalyaniU.S. Food and Drug Administration, Division of Biometrics V, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research.
Gary L RosnerU.S. Food and Drug Administration, Oncology Center of Excellence.
Jianjin XuU.S. Food and Drug Administration, Division of Biometrics V, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research.
Manoj KhanalMedical College of Wisconsin, Division of Biostatistics, Wisconsin, U.S.A.
Kwang Woo AhnMedical College of Wisconsin, Division of Biostatistics, Wisconsin, U.S.A.

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani · 2017 to 2026
$71.4M
Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
Easy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8M
NCATS NIH HHS UL1 TR001436NCI NIH HHS U24 CA076518NHLBI NIH HHS U10 HL069294NHLBI NIH HHS U24 HL138660
6 · The paper itself

Abstract

Using historical controls for clinical trial data analysis may increase statistical power and reduce required sample sizes when studying rare diseases. Most existing literature on borrowing information from historical controls with survival outcomes studied right-censored data. However, events of interest are often confirmed during routine follow-up visits or when patients display symptoms, leading to the recording of events after their occurrence. Treating these recorded events as an exact time rather than as interval-censored data may introduce bias into the assessment of treatment effect. When combining data sources, differential patterns of assessment timing may impact the comparability of the data and contribute to bias unless properly accounted for. Additionally, historical controls are often obtained by matching with clinical trial data, or which existing commensurate prior models have not been explored. To address these issues, we propose commensurate prior models with random effects for matched interval-censored survival data. These models effectively borrow information based on the degree of comparability between historical controls and clinical trial data. Simulation studies demonstrate the model's ability to control Type I error well, where the two data sources exhibit exchangeability or non-exchangeability. We apply our proposed methods by reanalyzing data from BMT CTN 1101 and BMT CTN 0901, incorporating corresponding historical datasets.

Indexed as

Borrowing from historical dataCommensurate priorInterval-censored dataMatching

Identifiers

PMID42445526
PMCPMC13364198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.